Mapping a conserved conformational epitope from the M protein of group a streptococci

Peptide Research

Volumn 9, Issue 1, 1996, Pages 12-20

  Reif, W A ^a,d   Cooper, J ^a   Brandt, E R ^a   Hayman, W A ^b   Anders, R F ^c   Pruksakorn, S ^a   Currie, B ^a   Saul, A ^b   Good, M E ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CARRIER PROTEIN; EPITOPE; HYBRID PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN; TRIFLUOROETHANOL;

ABORIGINE; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; CIRCULAR DICHROISM; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; MOUSE STRAIN; NUCLEOTIDE SEQUENCE; PEPTIDE MAPPING; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; RHEUMATIC FEVER; STREPTOCOCCUS PYOGENES;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; CIRCULAR DICHROISM; CONSERVED SEQUENCE; EPITOPES; HUMANS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; OCEANIC ANCESTRY GROUP; PEPTIDE MAPPING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; RHEUMATIC FEVER; STREPTOCOCCUS PYOGENES; TRIFLUOROETHANOL;

EID: 0030026502     PISSN: 10405704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ahlers, J.D., C.D. Pendleton, N. Dunlop, A. Minassian, P.L. Nara and J.A. Berzofsky. 1993. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple haplotypes after two immunizations. J. Immunol. 150:56475665.
2. Alonso, P.L., T. Smith, J.R.M.A. Schellenberg, H. Masanja, S. Mwankusye, H. Urassa, I. Bastos de Azevedo, J. Chongela, et al. 1994. Randomised trial of efficacy of SPf66 vaccine against Plusmodium falciparum malaria in children in southern Tanzania. The Lancet-Will 75-1181.
3. Barnett, L.A. and M.W. Cunningham. 1990. A new heart- cross-reactive antigen in Streptococcus pyrogenes is not M protein. J. Infect. Dis. 762:875-882.
4. Beachey, E.H., J.M. Seyer and J.B. Dale. 1987. Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequence of types 5, 6. and 24 M proteins synthesized in tandem. J. Exp. Med. 766:647-656.
5. Bessen, D. and V.A. Fischetti. 1988. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect. Immun. 56:2666-2672.
6. Bessen, D. and V.A. Fischetti. 1990. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat epitopes. J. Immunol. 145:1251-1256.
7. Bronze, M.S., E.H. Beachey and J.B. Dale. 1988. Protective and heart-cross reactive epitopes located within the NH2 terminus of type 19 streptococcal M protein. J. Immunol. 767:1849-1859.
8. Bronze, M.S., H.S. Courtney and J.B. Dale. 1992. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J. Immunol. 745:888-893.
9. Cohen, C. and D.A.D. Parry. 1990. ex-Helical coiled coils and bundles: how to design an exhelical protein. Proteins: Struct. Funct. Genet. 7:1-15.
10. Cunningham, M.W., N.K. Hall, K.K. Krisher and A.M. Spanies. 1986. A study of antigroup A streptococcal monoclonal antibodies cross-reactive with myosin. J. Immunol. 756:293-298.
11. l.Currie, B. 1993. Medicine in tropical Australia. Med. J. Aust. 609:612-615.
12. Dale, J.B. and E.H. Beachey. 1982. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membranes of human heart. J. Exp. Med. 756:1165-1176.
13. Dale, J.B., E.Y. Chiang and J.W. Lederer. 1993. Recombinant tetravalent group A streptococcal M protein vaccine. J. Immunol. 757:2188-2194.
14. H.Fischetti, V.A. 1989. Streptococcal M protein. Molecular design and biological behaviour. Clin. Microbiol. Rev. 2:285-314.
15. Hollingshead, S.K., V.A. Fischetti and J.R. Scott. 1986. Complete nucleotide sequence of type 6 M protein of the group A streptococcus. Repetitive structure and membrane anchor. J. Biol. Chem. 267:1677-1686.
16. Houghten, R.A. 1985. General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 82:5131-5135.
17. Kaplan, E.L. 1993. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Influences and dynamics of populations and pathogens: a failure to realize prevention. Circulation 88:1964-1972.
18. IS.Kemeny, E., T. Grieve, R. Marcus, P. Sareli and J.B. Zabriskie. 1989. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin. Immunol. Immunopathol. 52:225-237.
19. Kraus, W., J.B. Dale and E.H. Beachey. 1990. Identification of an epitope of type 1 streptococcal M protein that is shared with a 43kDa protein of human myocardium and renal glomeruli. J. Immunol. 745:4089-4093.
20. Liew, C.-C., M.J. Sole, K. Yamauchi-Takihara, B. Kellani, D.H. Anderson, L. Lin and J.C. Liew. 1990. Complete sequence and organisation of the human cardiac Beta-myosin heavy chain gene. Nucleic Acids Res. /S:3647-3651.
21. 0'Shea, E.K., J.D. Klemm, P.S. Kim and T. Alber. 1991. X-ray structure of the GCN4 leucine zipper, a two stranded, parallel coiled-coil. Science 254:539-544.
22. Pruksakorn, S., B. Currie, E. Brandt, D. Martin, A. Galbraith, C. Phornphutkul, S. Hunsakunachai, A. Manmontri and M.F. Good. 1994. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. The Lancet 344:639-642.
23. Pruksakorn, S., B. Currie, E. Brandt, C. Phornphutkul, S. Hunsakunachai, A. Manmontri, J.H. Robinson, M.A. Kehoe, A. Galbraith and M.F. Good. 1994. Identification of T-cell autoepitopes that cross-react with the carboxyterminal segment of the M protein of group A streptococci. Int. Immunol. 0:1235-1244.
24. Pruksakorn, S., A. Galbraith, R.A. Houghten and M.F. Good. 1992. Conserved T and B cell epitopes on the M protein of group A streptococci: induction of bactericidal antibodies. J. Immunol. 149:2729-2135.
25. Pruksakorn, S., C. Phronphutkul, S. Boonchoo, S. Suprasert, M. Krairojananan, A. Boonthum, T. Murai, Y. Inazumi, P. Sriburee and P. Tharavichitkul. 1990. Prevalence of group A streptococci from school children and patients in Chiang Mai, Thailand. Chiang MaiMed. Bull. 29:15.
26. Robinson, J.H., M.C. Atherton, J.A. Goodacre, M. Pinkney, H. Weightman and M.A. Kehoe. 1991. Mapping of T-cell epitopes in group A streptococcal type 5 M protein. Infect. Immunol. 59:4324-4331.
27. Robinson, J.H., M.C. Case and M.A. Kehoe. 1993. Characterization of a conserved helper-T-cell epitope from group A streptococcal M proteins. Infect. Immunol. 67:10621068.
28. Robinson, J.H and M.A. Kehoe. 1992. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol. Today 73:362-367.
29. Saez, L. and L.L. Leinwand. 1986. Characterization of diverse forms of myosin heavy chain expressed in adult human skeletal muscle. Nucleic Acids Res. 74:2951 -2968.
30. Sastry, K.J., B.S. Bender, W. Bell, P.A. Small, Jr. and R.B. Arlinghaus. 1994. Effects of influenza virus-specific cytotoxic Tlymphocyte responses induced by a synthetic nucleoprotein peptide on the survival of mice challenged with a lethal dose of virus. Vaccine 72:1281-1287.
31. Scalzo, A.A., S.L. Elliott, J. Cox, J. Gardner, D.J. Moss and A. Suhrbier. 1995. Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J.Virol. 69:1306-1309.
32. Stollerman, G.H. and J.H. Rusoff. 1952 Prophylaxis against group A streptococcal infections in rheumatic fever patients. J.A.M.A. 750:1571-1578.
33. WHO Programme for the Prevention of Rheumatic Fever/Rheumatic Heart Disease in 16 Developing Countries: report from phase I (1986-90). 1992. Bull. World Health Organ. 70:213-218.
34. Yang, L.C., P.R. Soprey, M.K. Wittner and E.N. Fox. 1977. Streptococcal induced cell-mediated-immune destruction of cardiac myofibers in vitro. J. Exp. Med. 746:344-360.